Arkolith/Insider Trading/SER/Form 4

Moreadith Randall

Chief Scientific OfficerSerina Therapeutics, Inc. (SER) · full profile →Form 4 · filed Dec 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10K
Net Open-Market Flow
-$10K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2025Sell(S)3K$2.96$10K0
Dec 16, 2025Option exercise(M)3K$0.06$1943K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2025Option exercise(M)3K—$0362K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001301120-25-000035) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML